Effect of surfactant type and concentration on the duration of mucoadhesion of carbopol 934 and HPMC solid compacts

Iranian Journal of Pharmaceutical Research

Volumn 2, Issue 4, 2003, Pages 191-199

  Mortazavi, Seyed Alireza ^a   Moghimi, Hamid Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbopol 934; Duration of mucoadhesion; Hydroxypropylmethyl cellulose; Mucoadhesion; Mucoadhesivity ratio; Surfactants

Indexed keywords

EID: 77953237876     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/ijpr.2010.55     Document Type: Article

References (22)

1. Hass J and Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin. Biol. Ther. (2002) 2: 287-298
2. Takeuchi H, Yamamoto H and Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. (2001) 47: 39-54
3. Lee JW, Park JH and Robinson JR. Bioadhesivebased dosage forms: the next generation. J. Pharm. Sci. (2000) 89: 850-866
4. Langoth N, Kalbe J and Bernkop-Schnurch A. Development of buccal drug delivery systems based on a thiolated polymer. Int. J. Pharm. (2003) 252:141-148
5. Smitha R and Kaur IP. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. (2002) 28: 353-369
6. Mortazavi SA. An investigation on the Mechanism of Mucoadhesion. (Ph. D. thesis), School of Pharmacy, University of Portsmouth, United Kingdom, 1993
7. Mortazavi SA and Smart JD. An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J. Contrl. Rel. (1993) 25: 197-203
8. Ahuja A, Khar RK and Ali J. Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. (1997) 23:489-515
9. Singla AK, Chawla M and Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev. Ind. Pharm. (2000) 26: 913-924
10. Madsen F, Eberth K and Smart JD. A rheological assessment of the nature of interactions between mucoadhesive polymers and a homogenised mucus gel. Biomaterials (1998) 19: 1083-1092
11. Mortazavi SA and Smart JD. An investigation of some factors influencing the invitro assessment of mucoadhesion. Int. J. Pharm. (1995) 116: 223-230
12. Mortazavi SA and Aboofazeli R. Preparation and invitro assessment of various mucosa-adhesive films for buccal delivery. DARU (2000) 8: 9-18
13. Mortazavi SA and Smart JD. Factors influencing gel strengthening at the mucoadhesive-mucus interface. J. Pharm. Pharmacol. (1994) 46: 86-90
14. Jain AC, Aungst BJ and Adeyeye MC. Development and invivo evaluation of buccal teblets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes. J. Pharm. Sci. (2002) 91: 1659-1668
15. st National Conference on Novel Drug Delivery Systems, Shaheed Beheshti University of Medical Sciences. Tehran (2003) p30
16. Tobyn MJ, Johnson JR and Dettmar PW. Factors affecting in-vitro gastric mucoadhesion: influence of tablet excipients, surfactants and salts on the observed mucoadhesion of polymers. Eur. J. Pharm. Biopharm. (1997) 43: 65-71
17. Sajadi-Tabassi SA, Martin GP and Marriott C. The effects of polysorbate surfactants on the structure of mucus glycoproteins. DARU (2001) 9: 6-11
18. Lehr CM, Bouwstra JA, Bodde HE and Junginger HE. A surface energy analysis of mucoadhesion:contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharm. Res. (1992) 9: 70-75
19. Mortazavi SA. Investigation of various parameters influencing the duration of mucoadhesion of some polymer containing discs. DARU (2002) 10: 98-104
20. Mortazavi SA and Smart JD. An in-vitro method for assessing the duration of mucoadhesion. J. Contrl. Rel. (1994) 31: 207-212
21. Smart J.D. An invitro assessment of some mucosaadhesive dosage forms. Int. J. Pharm. (1991) 73: 69-74
22. Mortazavi SA. A comparative study between the strength and duration of mucosa-adhesion of transbuccal carbomer based aqueous gels. Iran. J. Pharm. Res. (2002) 1: 7-15